Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 23373 | 348 | 34.8 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 210 | 3 | IMMUNOLOGY//JOURNAL OF INTERFERON RESEARCH//NK CELLS | 51916 |
| 328 | 2 | NK CELLS//NATURAL KILLER CELLS//KIR | 18140 |
| 23373 | 1 | IMMUNOL BIOTHER Y PROGRAM//INTERLEUKIN 2//MHC NONRESTRICTED CYTOTOXICITY | 348 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | IMMUNOL BIOTHER Y PROGRAM | address | 175489 | 1% | 100% | 2 |
| 2 | INTERLEUKIN 2 | authKW | 145404 | 22% | 2% | 76 |
| 3 | MHC NONRESTRICTED CYTOTOXICITY | authKW | 116992 | 1% | 67% | 2 |
| 4 | 1L 2 THERAPY | authKW | 87745 | 0% | 100% | 1 |
| 5 | ACTIVATED BONE MARROW | authKW | 87745 | 0% | 100% | 1 |
| 6 | ACUTE LEUKEMIA FRENCH ASSOC | address | 87745 | 0% | 100% | 1 |
| 7 | ACUTE MYELOID LEUKEMIA LINE | authKW | 87745 | 0% | 100% | 1 |
| 8 | ADHERENT LYMPHOCYTES | authKW | 87745 | 0% | 100% | 1 |
| 9 | ADVANCED REFRACTORY LYMPHOMAS | authKW | 87745 | 0% | 100% | 1 |
| 10 | ANTECEDENT HEMATOLOGIC DISORDER | authKW | 87745 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Hematology | 14660 | 62% | 0% | 216 |
| 2 | Oncology | 4184 | 56% | 0% | 196 |
| 3 | Transplantation | 3015 | 20% | 0% | 68 |
| 4 | Immunology | 1562 | 33% | 0% | 114 |
| 5 | Medicine, Research & Experimental | 121 | 8% | 0% | 28 |
| 6 | Cell & Tissue Engineering | 2 | 0% | 0% | 1 |
| 7 | Medicine, General & Internal | 0 | 2% | 0% | 8 |
| 8 | Surgery | 0 | 3% | 0% | 10 |
| 9 | Cell Biology | 0 | 3% | 0% | 9 |
| 10 | Medical Laboratory Technology | 0 | 0% | 0% | 1 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | IMMUNOL BIOTHER Y PROGRAM | 175489 | 1% | 100% | 2 |
| 2 | ACUTE LEUKEMIA FRENCH ASSOC | 87745 | 0% | 100% | 1 |
| 3 | BMT CELLULAR THER Y UNIT | 87745 | 0% | 100% | 1 |
| 4 | BONE MARROW TRANSPLANT CELLULAR THER Y UNIT | 87745 | 0% | 100% | 1 |
| 5 | CANC REGISTRY STAT | 87745 | 0% | 100% | 1 |
| 6 | CELLULAR THER Y HEMATOL UNIT | 87745 | 0% | 100% | 1 |
| 7 | CLIN MANAGEMENT OFF | 87745 | 0% | 100% | 1 |
| 8 | DRK BLUTSPENEDHENST BADEN WUTTEMBERG HESSEN | 87745 | 0% | 100% | 1 |
| 9 | GIMEMA COOPERAT GRP | 87745 | 0% | 100% | 1 |
| 10 | HAEMATOL HAEMOTRANSFUS SERV | 87745 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BONE MARROW TRANSPLANTATION | 24988 | 14% | 1% | 50 |
| 2 | NATURAL IMMUNITY AND CELL GROWTH REGULATION | 14052 | 1% | 3% | 5 |
| 3 | LEUKEMIA | 9106 | 8% | 0% | 28 |
| 4 | LEUKEMIA RESEARCH | 7015 | 6% | 0% | 22 |
| 5 | JOURNAL OF HEMATOTHERAPY | 2897 | 1% | 2% | 2 |
| 6 | CANCER RESEARCH THERAPY & CONTROL | 2696 | 1% | 2% | 2 |
| 7 | LEUKEMIA & LYMPHOMA | 2584 | 4% | 0% | 15 |
| 8 | BLOOD | 2430 | 9% | 0% | 31 |
| 9 | EXPERIMENTAL HEMATOLOGY | 2200 | 3% | 0% | 12 |
| 10 | CANCER JOURNAL | 2121 | 2% | 0% | 6 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MANDELLI, F , CAPRIA, S , VIGNETTI, M , MELONI, G , (1999) USE OF INTERLEUKIN-2 IN THE MANAGEMENT OF HAEMATOLOGICAL MALIGNANCIES - FOCUS ON MINIMAL RESIDUAL DISEASE.BIODRUGS. VOL. 12. ISSUE 1. P. 43 -53 | 38 | 60% | 3 |
| 2 | FOA, R , (1996) INTERLEUKIN 2 IN THE MANAGEMENT OF ACUTE LEUKAEMIA.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 92. ISSUE 1. P. 1-8 | 40 | 53% | 17 |
| 3 | VAN BESIEN, K , MEHRA, R , WADEHRA, N , STOCK, W , KHOURI, I , GIRALT, S , DEVINE, S , WICKREMA, A , PEACE, D , SOSMAN, J , ET AL (2004) PHASE II STUDY OF AUTOLOGOUS TRANSPLANTATION WITH INTERLEUKIN-2-INCUBATED PERIPHERAL BLOOD STEM CELLS AND POSTTRANSPLANTATION INTERLEUKIN-2 IN RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMA.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 10. ISSUE 6. P. 386-394 | 28 | 56% | 6 |
| 4 | MARGOLIN, KA , WRIGHT, C , FORMAN, SJ , (1997) AUTOLOGOUS BONE MARROW PURGING BY IN SITU IL-2 ACTIVATION OF ENDOGENOUS KILLER CELLS.LEUKEMIA. VOL. 11. ISSUE 5. P. 723-728 | 22 | 79% | 15 |
| 5 | GOODMAN, M , CABRAL, L , CASSILETH, P , (1998) INTERLEUKIN-2 AND LEUKEMIA.LEUKEMIA. VOL. 12. ISSUE 11. P. 1671 -1675 | 26 | 57% | 21 |
| 6 | PAWELEC, G , (1994) MHC-UNRESTRICTED IMMUNE SURVEILLANCE OF LEUKEMIA.CANCER BIOTHERAPY. VOL. 9. ISSUE 3. P. 265-288 | 55 | 30% | 6 |
| 7 | FOA, R , (1993) DOES INTERLEUKIN-2 HAVE A ROLE IN THE MANAGEMENT OF ACUTE-LEUKEMIA.JOURNAL OF CLINICAL ONCOLOGY. VOL. 11. ISSUE 9. P. 1817-1825 | 31 | 48% | 43 |
| 8 | MELONI, G , VIGNETTI, M , POGLIANI, E , INVERNIZZI, R , ALLIONE, B , MIRTO, S , SICA, S , LEONI, F , SELLERI, C , MANDELLI, F , (1997) INTERLEUKIN-2 THERAPY IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA.CANCER JOURNAL. VOL. 3. ISSUE . P. S43 -S47 | 15 | 88% | 17 |
| 9 | MELONI, G , VIGNETTI, M , ANDRIZZI, C , CAPRIA, S , FOA, R , MANDELLI, F , (1996) INTERLEUKIN-2 FOR THE TREATMENT OF ADVANCED ACUTE MYELOGENOUS LEUKEMIA PATIENTS WITH LIMITED DISEASE: UPDATED EXPERIENCE WITH 20 CASES.LEUKEMIA & LYMPHOMA. VOL. 21. ISSUE 5-6. P. 429-435 | 18 | 75% | 22 |
| 10 | BLAISE, D , MARANINCHI, D , (1998) INTERLEUKIN 2 IN THE TREATMENT OF ACUTE LEUKEMIA.LEUKEMIA RESEARCH. VOL. 22. ISSUE 12. P. 1165 -1170 | 18 | 69% | 4 |
Classes with closest relation at Level 1 |